Enjoy complimentary customisation on priority with our Enterprise License!
The global label-free detection (LFD) market size is estimated to grow by USD 362.6 million between 2021 to 2026 accelerating at a CAGR of 7.79%.
This label-free detection (LFD) market report extensively covers market segmentation by End-user (pharmaceutical and biotechnology companies, contract research organizations (cros), and academic and research institutes), Product (biochemical assays and cell-based assays), and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
LFD has different types of advantages. Label-free technology has gained momentum as an innovative tool, especially in the fields of cellular research and biochemical binding assays. For cell-based assays, label-free technology of detection offers various advantages, which include the recording of the integrated global response of cells, as well as the ability to monitor endogenously expressed receptors with high sensitivity. Increasing demand has emerged for label-free technology as a widely accepted research tool for the mechanism of action (MOA) studies in lead optimization and receptor pharmacology and as a robust system for monitoring proteins. This factor is prominently driving the market growth.
View the Bestselling Market Research Sample
Factors such as the rise in drug discovery problems, and the increase in contract research organizations (CROs) in developing countries are also driving market growth.
In 2020 and 2021, the regional market in question experienced growth as a result of the COVID-19 outbreak and the utilization of LFD to detect SARS-CoV-2. Health and research institutions in North America have been rapidly developing new methods to detect COVID-19, with LFD emerging as a promising technique. LFD involves the use of a biosensor and detection instrument to monitor viral load, enabling the capture and digital counting of intact virus particles in saliva or exhaled breath. This approach provides a more cost-effective and faster means of diagnosing infections. Furthermore, ongoing research and development on COVID-19 in North America are expected to drive the growth of the regional market during the forecast period.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rise in chronic diseases has led to an increase in drug discovery, with various academic and research institutes organizing drug discovery programs globally. These programs assist in testing the toxicity and efficacy of drugs. Partnerships between academic research institutes and major pharmaceutical/biotechnology companies are also increasing. For example, Corning showcased its technologies for 3D cell culture and drug discovery at the SLAS conference 2022. Oncodesign is another drug discovery program that aids in the discovery of novel protein kinase inhibitors for cancer therapy. LFD for drug discovery is offered by various vendors, such as Corning, as it simplifies detection and reduces testing costs. The growing drug discovery programs and the use of LFD in drug discovery are expected to boost the growth of the market during the forecast period.
The growing demand for LFD from biomedical R and D and drug discovery has led to various developments in LFD technology. Thus, vendors are launching new LFD systems owing to the high demand for LFD by various end-users, such as pharmaceutical and biotechnology companies. Some of the instances are given below:
Thus, the increasing product launches by the vendors operating in the market will drive the growth of the market in focus during the forecast period.
The global LFD market is renowned for its product efficacy and sensitivity, but combining both with high throughput is a significant challenge. Vendors are working on product development, but handling combination analyzers that run thousands of samples without automation or skilled professionals is difficult. Integrated systems can reduce contamination risks and increase sample detection sensitivity, but they require specific consumables and are incompatible with those from other companies.
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bio-rad- The company offers label free detection system namely ProteOn XPR36 protein interaction array system.
The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market vendors, including:
Technavio’s report consists of a holistic analysis of the key development Analysis, development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.
The label-free detection (LFD) market share growth in the pharmaceutical and biotechnology companies segment will be significant during the forecast period. Pharmaceutical and biotechnology companies are the largest contributing end-user segment to the growth of the global LFD market. Many such companies are operating in the market in focus. These companies are engaged in drug discovery and product development. Pharmaceutical and biopharmaceutical companies develop drug molecules for a wide array of therapeutic applications.
To gain further insights on the market contribution of various segments View Sample PDF
Label-free biochemical assays measure changes in the index of refraction upon a binding event. This change is indicated by a shift in wavelength. In biochemical assays, LFD has the advantage over functional assays of recording actual binding events rather than the downstream functional effect of binding. It provides access to novel biochemical and pharmacological information for basic research and drug discovery which is driving the market growth.
For more insights on the market share of various regions View PDF Sample now!
40% of the market’s growth will originate from North America during the forecast period. The US is the key market for the label-free detection (LFD) market in North America. Market growth in this region will be faster than the growth in other regions.
The rise in drug discovery programs will facilitate the LFD market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
Label-free Detection (LFD) Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.79% |
Market growth 2022-2026 |
USD 362.6 million |
Market structure |
Fragmented |
YoY growth (%) |
7.06 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key consumer countries |
US, Germany, UK, France, and China |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Affinite Instruments, Agilent Technologies Inc., AMETEK Inc., Attana AB, Bio Rad Laboratories Inc., BioNavis Ltd., BiOptix Analytical LLC, Bruker Corp., Corning Inc., Danaher Corp., HORIBA Ltd., OLS OMNI Life Science GmbH and Co. KG, PerkinElmer Inc., Sartorius AG, Spectris Plc, SYMCEL, Thermo Fisher Scientific Inc., Waters Corp., Wyatt Technology Corp., and General Electric Co. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.